Invest for Impact

Chipscreen Biosciences[688321.SH] is a leading enterprise of small molecule innovative medicines in China. Vertex Ventures was the first institutional investor to back Chipscreen when it was founded in 2001. Chipscreen announced its IPO on STAR Market of SSE in 2019.

Horizon Roboticsis one of the world’s most valuable, unicorn AI startups. Vertex Ventures China led investment in its Series A round in 2016. It also secured follow-on funding from SK group, Inter and the CITIC securities.

Geek+is a leading robotics and AI technologies provider and China’s supplier of warehousing and logistics solutions. Vertex Ventures China led Series A+ funding round in 2017. It also secured follow-on funding from Warburg Pincus, GGV, Intel, CPE etc.

SmartXCEO & Founder Wenhao Xu says, “Vertex Ventures China always stands with the founders and focuses on the long-term development of startups. The various post-investment service from Vertex indeed help us grow and develop.”

RecBio[02179.HK] is the vaccine company with a high-value vaccine portfolio driven by in-house developed technologies. RecBio announced its IPO on HKSE in 2022.

ArrayCommCEO Xin Huang says, “Vertex Ventures China is a tech-savvy investment team，and also a good partner with ArrayComm. The post-investment team gave us warm support to help us advance easily and speedily. Thanks to Vertex.”

Harbour Biomed[02142.HK] is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology. Vertex Ventures China invested in its Series B round in 2018. It completed its global IPO on HKEX in 2020.

mobikeis a bike sharing service to fulfill urban short trips by combining innovation and today’s IoT technology. Vertex Ventures China led investment in its Series B+ round in 2016. Mobike has been fully acquired by Meituan [3960.HK] in 2018.

Unitreeis an energetic startup that focuses on high-performance quadruped robots. Vertex Ventures China invested in its Series Pre-A funding.

Wangxiaoluis a famous online women’s underwear and lingerie brand. Vertex Ventures China led investment in its Series B round. It also secured follow-on funding from The Carlyle Group, Qiming Venture Partners, etc.

NEIWAIis a high-tech enterprise focusing on high-reliability and high-performance automotive SoC. Vertex Ventures China, as the earliest investor, invested in its Series Pre-A, Series A and Series B financing.

SemiDrivehas focused on providing high-performance and high-reliability automotive-grade chips and is also the first provider of “full-scenario and platform-based” chip product and technical solutions in the world. Vertex Ventures China has invested in its Series Pre-A, A, B round.

91 Wirelesshas been one of the largest Android app stores in China. It was acquired in 2014 by Baidu [BIDU] for $1.9B. Vertex Ventures China achieved over $100M returns after the investment in 2012.

AnHeartis a clinical-stage global biopharmaceutical company developing a broad pipeline of novel precision oncology therapeutics with high unmet medical needs. Vertex China invested in its A round in 2020. AnHeart was fully acquired by Nuvation Bio[NYSE: NUVB] in 2024.